about
Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence?Inverse relationship between Alzheimer's disease and cancer, and other factors contributing to Alzheimer's disease: a systematic review.Transcriptomics Profiling of Alzheimer's Disease Reveal Neurovascular Defects, Altered Amyloid-β Homeostasis, and Deregulated Expression of Long Noncoding RNAsBrain site-specific proteome changes in aging-related dementia.Oligodendrocytes and Alzheimer's disease.Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.Effects of ginsenoside Rg1 on the expression of toll-like receptor 3, 4 and their signalling transduction factors in the NG108-15 murine neuroglial cell line.Epigenetic drugs for Alzheimer's disease.Targeted proteomics for quantification of histone acetylation in Alzheimer's disease.Omics Approaches for Identifying Physiological Adaptations to Genome Instability in Aging.IRF-8 is Involved in Amyloid-β1-40 (Aβ1-40)-induced Microglial Activation: a New Implication in Alzheimer's Disease.Improving animal models for nervous system disorders.No association of the variant rs11887120 in DNMT3A with cognitive decline in individuals with mild cognitive impairment.DNMT3A moderates cognitive decline in subjects with mild cognitive impairment: replicated evidence from two mild cognitive impairment cohorts.DNA methylation of the TNF-α promoter region in peripheral blood monocytes and the cortex of human Alzheimer's disease patients.
P2860
Q28071699-B1B7F6EA-9D6A-44F1-8539-23F36458DD30Q36201349-85FEDADB-9BE8-4C9D-B9C3-5A38DF83CDB8Q36421684-1A29F367-D19E-4DFF-A603-EAF017F7CF6AQ37212178-0D0A88F4-7BAE-4076-BCC7-3810310F7821Q38497880-3AC00EFB-7888-4F7A-BC07-ECA6D0A39A3FQ38664541-3E567CA0-F18C-4B74-9C47-9E70D6F3B2D8Q38945601-9D3A3049-3693-421C-AB41-AFEF22AF86BCQ39456677-AA5B895B-0311-47AF-9F00-3CFC4F583A37Q44787901-3414CA2F-0E82-4F97-972C-056519B8EB1BQ47097416-D86713BD-A5B1-4666-817C-32A18812F145Q47879568-64EDF441-306F-4F80-9E48-D8D5E6E9C5A8Q48518619-F7AA44D5-2EB8-4F7E-B2FF-78E804DDF9A3Q50217511-F00AF88D-A00D-4F86-AD7A-478949F4FB45Q50581281-41A143A3-AFC0-416C-BB74-371F25A4A180Q51110008-A0DC793C-D3D8-43A0-8798-C53D3629551B
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Epigenetic mechanisms in Alzheimer's disease.
@ast
Epigenetic mechanisms in Alzheimer's disease.
@en
Epigenetic mechanisms in Alzheimer's disease.
@nl
type
label
Epigenetic mechanisms in Alzheimer's disease.
@ast
Epigenetic mechanisms in Alzheimer's disease.
@en
Epigenetic mechanisms in Alzheimer's disease.
@nl
prefLabel
Epigenetic mechanisms in Alzheimer's disease.
@ast
Epigenetic mechanisms in Alzheimer's disease.
@en
Epigenetic mechanisms in Alzheimer's disease.
@nl
P2093
P1476
Epigenetic mechanisms in Alzheimer's disease.
@en
P2093
Daniilidou M
Koutroumani M
P304
P356
10.2174/092986711795496872
P577
2011-01-01T00:00:00Z